| API | Produktname | FALL NR. | Einstufung |
| Canagliflozin | 2-(4-Fluorphenyl)-5-[(5-iod-2-methylphenyl)methyl]thiophen | 898566-17-1 | Diabetes |
| Empagliflozin | (3S)-3-[4-[(5-Brom-2-chlorphenyl)methyl]phenoxy]tetrahydrofuran | 915095-89-5 | Diabetes |
| Linagliptin | 8-Brom-7-(but-2-inyl)-3-methyl-1H-purin-2,6(3H,7H)-dion | 666816-98-4 | Diabetes |
| Linagliptin | 2-(Chlormethyl)-4-methylchinazolin | 109113-72-6 | Diabetes |
| Linagliptin | 8-Brom-7-but-2-inyl-3-methyl-1-(4-methyl-chinazolin-2-ylmethyl)-3,7-dihydro-purin-2,6-dion | 853029-57-9 | Diabetes |
| Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexan-2-carbonsäure-tert-butylester | 361440-67-7 | Diabetes |
| Saxagliptin | (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decan-1-essigsäure | 361442-00-4 | Diabetes |
| Sitagliptin | 2,4,5-Trifluorphenylessigsäure | 209995-38-0 | Diabetes |
| Sitagliptin | Boc-(R)-3-Amino-4-(2,4,5-trifluor-phenyl)-buttersäure | 486460-00-8 | Diabetes |
| Sitagliptin | 3-(Trifluormethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazinhydrochlorid | 762240-92-6 | Diabetes |
| Vildagliptin | L-Prolinamid | 7531-52-4 | Diabetes |
| Vildagliptin | (2S)-1-(Chloracetyl)-2-pyrrolidincarbonitril | 207557-35-5 | Diabetes |
| Empagliflozin Dapagliflozin/Canagliflozin | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolacton | 32384-65-9 | Diabetes |
| Vildagliptin | L-Prolinamid | 7531-52-4 | Diabetes |
| Liraglutid | Liraglutid | 204656-20-2 | Diabetes |
| ABT-888 | (S)-2-Methylprolin | 42856-71-3 | Anti-Krebs |
| Docetaxel | 10-Deacetylbaccatin III | 32981-86-5 | Anti-Krebs |
| Lenvatinib | 4-Chlor-7-methoxychinolin-6-carboxamid | 417721-36-9 | Anti-Krebs |
| Lenvatinib | 4-Amino-3-chlorphenolhydrochlorid | 52671-64-4 | Anti-Krebs |
| Acalabrutinib | (3-Chloropyrazin-2-yl)MethanaMinhydrochlorid | 939412-86-9 | Anti-Krebs |
| Acalabrutinib | N-Benzyloxycarbonyl-L-prolin | 1148-11-4 | Anti-Krebs |
| Acalabrutinib | N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamid | 1383385-64-5 | Anti-Krebs |
| Acalabrutinib | 2-Butinsäure | 590-93-2 | Anti-Krebs |
| Nilotinib | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluormethyl)anilin | 641571-11-1 | Anti-Krebs |
| Nilotinib | Diphenylphosphorylazid | 26386-88-9 | Anti-Krebs |
| Nilotinib | 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoesäure | 641569-94-0 | Anti-Krebs |
| Nilotinib | 1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-on | 55314-16-4 | Anti-Krebs |
| Abirateronacetat | 17-Iodoandrosta-5,16-dien-3beta-ol | 32138-69-5 | Anti-Krebs |
| Abirateronacetat | 17-Iodoandrosta-5,16-dien-3beta-ol-3-acetat | 114611-53-9 | Anti-Krebs |
| Neratinib | 3-Chlor-4-(pyridin-2-ylmethoxy)anilin | 524955-09-7 | Anti-Krebs |
| Neratinib | N-(4-Chlor-3-cyano-7-ethoxy-6-chinolinyl)acetamid | 848133-76-6 | Anti-Krebs |
| Neratinib | 6-Amino-4-(3-chlor-4-(pyridin-2-ylmethoxy)phenylamino)-7-ethoxychinolin-3-carbonitril | 848139-78-6 | Anti-Krebs |
| Neratinib | trans-4-Dimethylaminocrotonsäurehydrochlorid | 848133-35-7 | Anti-Krebs |
| Palbociclib | tert-Butyl-4-(6-amino-3-pyridyl)piperazin-1-carboxylat | 571188-59-5 | Anti-Krebs |
| Palbociclib | 6-Brom-2-chlor-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-on | 1016636-76-2 | Anti-Krebs |
| Ribociclib | 2-Chlor-7-cyclopentyl-n,n-dimethyl-7h-pyrrolo[2,3d]pyrimidin-6-carboxamid | 1211443-61-6 | Anti-Krebs |
| Ribociclib | 2-Chlor-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-carbonsäure | 1211443-58-1 | Anti-Krebs |
| Ceritinib/Crizotinib | 4-(4-Brompyrazol-1-yl)piperidin-1-carbonsäure-tert-butylester | 877399-50-3 | Anti-Krebs |
| Ceritinib/Crizotinib | tert-Butyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidin-1-carboxylat | 877399-74-1 | Anti-Krebs |
| Ceritinib/Crizotinib | (S)-1-(2,6-Dichlor-3-fluorphenyl)ethanol | 877397-65-4;42247-74-5 | Anti-Krebs |
